Hillsdale Investment Management’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $109K | Hold |
1,275
| – | – | ﹤0.01% | 574 |
|
|
2025
Q4 | $101K | Buy |
+1,275
| New | +$100K | ﹤0.01% | 518 |
|
|
2025
Q3 | – | Sell |
-7,250
| Closed | -$659K | – | 658 |
|
|
2025
Q2 | $659K | Sell |
7,250
-100
| -1% | -$9.13K | 0.02% | 377 |
|
|
2025
Q1 | $689K | Hold |
7,350
| – | – | 0.04% | 317 |
|
|
2024
Q4 | $668K | Buy |
7,350
+300
| +4% | +$28.6K | 0.03% | 331 |
|
|
2024
Q3 | $732K | Buy |
+7,050
| New | +$719K | 0.06% | 296 |
|
|
2024
Q2 | – | Sell |
-7,000
| Closed | -$630K | – | 590 |
|
|
2024
Q1 | $630K | Sell |
7,000
-100
| -1% | -$8.47K | 0.05% | 265 |
|
|
2023
Q4 | $566K | Buy |
+7,100
| New | +$534K | 0.05% | 268 |
|
|
2021
Q1 | – | Sell |
-230
| Closed | -$20K | – | 556 |
|
|
2020
Q4 | $20K | Buy |
230
+120
| +109% | +$9.92K | ﹤0.01% | 482 |
|
|
2020
Q3 | $8K | Buy |
110
+70
| +175% | +$5.34K | ﹤0.01% | 507 |
|
|
2020
Q2 | $3K | Hold |
40
| – | – | ﹤0.01% | 519 |
|
|
2020
Q1 | $3K | Sell |
40
-10
| -20% | -$705 | ﹤0.01% | 542 |
|
|
2019
Q4 | $3K | Sell |
50
-20
| -29% | -$1.36K | ﹤0.01% | 553 |
|
|
2019
Q3 | $5K | Buy |
70
+20
| +40% | +$1.45K | ﹤0.01% | 551 |
|
|
2019
Q2 | $4K | Hold |
50
| – | – | ﹤0.01% | 546 |
|
|
2019
Q1 | $3K | Buy |
50
+20
| +67% | +$1.29K | ﹤0.01% | 559 |
|
|
2018
Q4 | $2K | Sell |
30
-20
| -40% | -$1.25K | ﹤0.01% | 548 |
|
|
2018
Q3 | $3K | Hold |
50
| – | – | ﹤0.01% | 425 |
|
|
2018
Q2 | $3K | Sell |
50
-5
| -9% | -$327 | ﹤0.01% | 443 |
|
|
2018
Q1 | $4K | Buy |
55
+15
| +38% | +$1.08K | ﹤0.01% | 397 |
|
|
2017
Q4 | $3K | Buy |
40
+10
| +33% | +$730 | ﹤0.01% | 425 |
|
|
2017
Q3 | $2K | Hold |
30
| – | – | ﹤0.01% | 428 |
|
|
2017
Q2 | $2K | Sell |
30
-10
| -25% | -$742 | ﹤0.01% | 431 |
|
|
2017
Q1 | $3K | Sell |
40
-40
| -50% | -$2.8K | ﹤0.01% | 410 |
|
|
2016
Q4 | $5K | Buy |
+80
| New | +$5.49K | ﹤0.01% | 387 |
|
|
2015
Q4 | – | Sell |
-2,900
| Closed | -$184K | – | 512 |
|
|
2015
Q3 | $184K | Sell |
2,900
-1,000
| -26% | -$65.3K | 0.06% | 328 |
|
|
2015
Q2 | $255K | Buy |
3,900
+1,100
| +39% | +$74.6K | 0.08% | 311 |
|
|
2015
Q1 | $194K | Sell |
2,800
-500
| -15% | -$34.6K | 0.05% | 345 |
|
|
2014
Q4 | $228K | Sell |
3,300
-200
| -6% | -$13.5K | 0.06% | 307 |
|
|
2014
Q3 | $228K | Buy |
3,500
+300
| +9% | +$19.8K | 0.07% | 283 |
|
|
2014
Q2 | $218K | Sell |
3,200
-400
| -11% | -$26.8K | 0.05% | 313 |
|
|
2014
Q1 | $234K | Buy |
3,600
+1,200
| +50% | +$75.6K | 0.07% | 278 |
|
|
2013
Q4 | $157K | Buy |
2,400
+100
| +4% | +$6.4K | 0.05% | 340 |
|
|
2013
Q3 | $136K | Sell |
2,300
-300
| -12% | -$17.8K | 0.04% | 322 |
|
|
2013
Q2 | $149K | Buy |
+2,600
| New | +$154K | 0.05% | 336 |
|
Other funds holding CL
VCM
DAM
VPM
Hillsdale Investment Management's CL Position: Q1 2026 in Review
Hillsdale Investment Management held its Colgate-Palmolive (CL) position steady in Q1 2026 at 1,275 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #574.
Hillsdale Investment Management first reported a position in CL in Q2 2013 and has held it in 35 quarters since. The position peaked at $732K in Q3 2024. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.
- Hillsdale Investment Management held 1,275 shares of Colgate-Palmolive worth $109K as of Q1 2026.
- Hillsdale Investment Management left its Colgate-Palmolive share count unchanged in Q1 2026.
- Colgate-Palmolive made up ﹤0.01% of Hillsdale Investment Management's portfolio in Q1 2026, its #574 holding.
- Hillsdale Investment Management first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 35 quarters since.
- Hillsdale Investment Management's Colgate-Palmolive position peaked at $732K in Q3 2024.
- 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.
Based on Hillsdale Investment Management's 13F filing for Q1 2026, filed 4 May 2026.